Sino Biological, Inc. (“Sino Biological” or the “Company”), a biotechnology firm listed on the Shenzhen inventory trade subsidiary ChiNext (SZSE: 301047), which offers organic analysis reagents and associated technical contract analysis providers, is happy to announce the formal signing of a lease with Hines and initiation of building on its new Center for Bioprocessing (C4B) at its Levit Green facility in Houston, Texas USA.
Image Credit: Sino Biological
Headquartered in Beijing, China with subsidiaries in Suzhou, China; Taizhou, China; Frankfurt, Germany; Kawasaki, Japan; and Wayne, Pennsylvania and listed on the Shenzhen inventory trade subsidiary ChiNext (SZSE: 301047), Sino Biological is the world’s main supplier of mammalian cell-based recombinant proteins, antibodies, and associated contract analysis providers. This new website serves as the corporate’s first US-based manufacturing facility. Referred to because the Center for Bioprocessing (C4B), the ability will give attention to each product manufacture and the implementation of contract analysis providers. Levit Green will additional set up its presence in Houston, offering corporations, teachers, and medical researchers within the world-renowned Texas Medical Center and throughout the area invaluable entry to Sino Biological’s complete providing of bioreagents and CRO providers.
We are extraordinarily enthusiastic about our new partnership with the Hines group and our forthcoming laboratories and manufacturing amenities at Levit Green. Hines is on the forefront of next-generation laboratory area design and growth, and our new website on the Levit Green master-planned district within the coronary heart of Houston’s Texas Medical Center will allow Sino Biological to significantly develop its analysis providers and bioreagent manufacture capabilities into the United States.”
Dr. Rob Burgess, Chief Business Officer, Sino Biological
“I am delighted about the development of the Center for Bioprocessing in Houston. I believe strongly in excellent science and cutting-edge technologies, and that’s why I joined Sino Biological. I have assembled a world-class team which is currently establishing the C4B with the ultimate goal to promote the scientific development of next-gen precision medicine therapeutic antibodies and proteins,” said Dr. Yingmin Zhu, the C4B’s Head.
“Levit Green was meticulously designed to provide best-in-class life science space that can accommodate a multitude of uses. Welcoming Sino Biological is a testament to the market need for sophisticated, flexible space that allows diversified firms to perform a variety of research,” mentioned John Mooz, senior managing director of Hines. “Sino Biological is an excellent addition to the district’s growing life science ecosystem, and we look forward to supporting their continued growth and success.”